CAR T-cell therapy for B-cell lymphoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference72 articles.
1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016
2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte;Coiffier;Blood,2010
3. Obinutuzumab for the first-line treatment of follicular lymphoma;Marcus;N Engl J Med,2017
4. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial;Rummel;Lancet,2013
5. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma;Philip;N Engl J Med,1987
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A dual-luciferase bioluminescence system for the assessment of cellular therapies;Molecular Therapy: Oncology;2024-03
2. Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma;Frontiers in Pediatrics;2024-01-12
3. A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023;Human Vaccines & Immunotherapeutics;2023-12-15
4. CAR T‐Cell Therapy for Multiple Myeloma: A Clinical Practice‐Oriented Review;Clinical Pharmacology & Therapeutics;2023-11-04
5. The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors;Frontiers in Immunology;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3